A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 2.58 USD 2.79% Market Closed
Market Cap: 255.1m USD

Intrinsic Value

The intrinsic value of one AQST stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.58 USD, Aquestive Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

AQST Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Aquestive Therapeutics Inc

AQST
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AQST cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AQST?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Aquestive Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aquestive Therapeutics Inc

Current Assets 88.2m
Cash & Short-Term Investments 71.5m
Receivables 7.3m
Other Current Assets 9.3m
Non-Current Assets 13.2m
PP&E 9m
Other Non-Current Assets 4.2m
Efficiency

Free Cash Flow Analysis
Aquestive Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aquestive Therapeutics Inc

Revenue
57.6m USD
Cost of Revenue
-17.9m USD
Gross Profit
39.7m USD
Operating Expenses
-70.5m USD
Operating Income
-30.8m USD
Other Expenses
-13.4m USD
Net Income
-44.1m USD
Fundamental Scores

AQST Profitability Score
Profitability Due Diligence

Aquestive Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
ROIC is Increasing
hidden
Profitability
Score

Aquestive Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

AQST Solvency Score
Solvency Due Diligence

Aquestive Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Negative Net Debt
Long-Term Solvency
hidden
Solvency
Score

Aquestive Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AQST Price Targets Summary
Aquestive Therapeutics Inc

Wall Street analysts forecast AQST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AQST is 10.06 USD with a low forecast of 4.8 USD and a high forecast of 15.75 USD.

Lowest
Price Target
4.8 USD
86% Upside
Average
Price Target
10.06 USD
290% Upside
Highest
Price Target
15.75 USD
510% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Aquestive Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AQST is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Ownership

AQST Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AQST stock?

The intrinsic value of one AQST stock under the Base Case scenario is hidden USD.

Is AQST stock undervalued or overvalued?

Compared to the current market price of 2.58 USD, Aquestive Therapeutics Inc is hidden .

Back to Top